Literature DB >> 9500323

Gemcitabine-associated autonomic neuropathy.

A J Dormann, T Grünewald, B Wigginghaus, H Huchzermeyer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500323     DOI: 10.1016/S0140-6736(05)78426-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies.

Authors:  Gerardo Gutiérrez-Gutiérrez; María Sereno; Ambrosio Miralles; Enrique Casado-Sáenz; Eduardo Gutiérrez-Rivas
Journal:  Clin Transl Oncol       Date:  2010-02       Impact factor: 3.405

Review 2.  Cancer-treatment-induced neurotoxicity--focus on newer treatments.

Authors:  Jacqueline B Stone; Lisa M DeAngelis
Journal:  Nat Rev Clin Oncol       Date:  2015-09-22       Impact factor: 66.675

3.  Kinetic investigation of the inhibitory effect of gemcitabine on DNA polymerization catalyzed by human mitochondrial DNA polymerase.

Authors:  Jason D Fowler; Jessica A Brown; Kenneth A Johnson; Zucai Suo
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

4.  Peripheral neuropathy due to therapy with paclitaxel, gemcitabine, and cisplatin in patients with advanced ovarian cancer.

Authors:  C C P Verstappen; T J Postma; K Hoekman; J J Heimans
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130

5.  Chemotherapy-induced polyneuropathy. Part I. Pathophysiology.

Authors:  Krzysztof Brzeziński
Journal:  Contemp Oncol (Pozn)       Date:  2012-02-29

Review 6.  Neuropathic cancer pain: What we are dealing with? How to manage it?

Authors:  Ece Esin; Suayib Yalcin
Journal:  Onco Targets Ther       Date:  2014-04-17       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.